COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.

Stojan PericMilos RankovicIvo BozovicVanja RadosavljevicIvan MarjanovicIvana BastaDragana Lavrnic

Published in: Acta neurologica Belgica (2022)

COVID-19 has placed a significant new burden for MG patients. Elder MG patients and patients with comorbidities are in higher risk of having adverse outcome following SARS-CoV-2 infection. Percentage of vaccinated MG patients was higher than in general Serbian population.

Keyphrases

end stage renal disease
sars cov
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
coronavirus disease
emergency department
myasthenia gravis
risk factors
respiratory syndrome coronavirus